ArticleJournal of medical Internet research2026
Clinical Effects of a Digital Health Intervention for Adults With Type 2 Diabetes in the United States: Retrospective Cohort Study.
Article in Journal of medical Internet research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDigital health interventions show promise in supporting adults with type 2 diabetes mellitus (T2DM). Dario is a digital diabetes solution (DDS) that allows individuals with T2DM to automatically log blood glucose (BG) measurements and other variables to facilitate positive behavior changes.
objectiveThis retrospective cohort study compared real-world clinical outcomes of adults with T2DM using the DDS with those of adults with T2DM receiving usual care alone.
methodsHealth care and claims data collected from the DDS, the Symphony Health Integrated Dataverse, and the Quest Laboratory were integrated into a single dataset using tokenization. DDS users were compared with a matched cohort of nonusers over the period from January 2017 to October 2021. Inclusion criteria were adults ≥18 years of age with T2DM, treated with antidiabetic medications, with ≥7% glycated hemoglobin (HbA
resultsThe two cohorts included 568 DDS users and 1699 nonusers with matched baseline characteristics. At 6 months, the generalized linear model least squares mean estimate of the difference in change in HbA
conclusionsAdults with T2DM and elevated HbA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.